Browse All

Current Filters

CLEAR FILTER x

TITLE

A Phase 2 Study of ATH434, a Novel Inhibitor of a-synuclein Aggregation, for the Treatment of Multiple System Atrophy (MSA)

Author:Stamler, David   Wong, Cynthia   Trujillo Diaz, Paula   Bradbury, Margaret   Lucas, Christine   Claassen, Daniel   

Session Name:P2: Movement Disorders: Atypical and Secondary Parkinsonisms 1  

Topic:Movement Disorders  

Program Number:P2.004  

Author Institution:Alterity Therapeutics, Newark, CA  Vanderbilt University Medical Center, Nashville, TN  

Neurofilament Light Chain and Clinical Progression in Early Multiple System Atrophy

Author:Claassen, Daniel   Trujillo Diaz, Paula   Wynn, Amy   Yan, Bailu   Kang, Hakmook   Bradbury, Margaret   Wong, Cynthia   Stamler, David   

Session Name:P5: Autonomic Disorders  

Topic:Autonomic Disorders  

Program Number:P5.001  

Author Institution:Vanderbilt University Medical Center, Nashville, TN  Vanderbilt University, Nashville, TN  Alterity Therapeutics, Newark, CA  

Effects of ATH434, a Clinical-phase Small Molecule with Moderate Affinity for Iron, in a Parkinson’s Disease Model in Macaques

Author:Bradbury, Margaret   Aumann, Megan   Claassen, Daniel   Finkelstein, David   

Session Name:P7: Movement Disorders: Parkinson's Disease Basic Science  

Topic:Movement Disorders  

Program Number:P7.010  

Author Institution:Alterity Therpeutics, Newark, CA  Vanderbilt University Medical Center, Nashville, TN  Florey Institute of Neuroscience and Mental Health, Melbourne, Australia